ScreenerHero

CNXU Conexeu Sciences Inc.

NAS · US · Healthcare · Biotechnology · conexeu.com
3.640USD-0.55%Mkt Cap: 102.67M $P/E: —

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a co…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap102.67M USD
Enterprise Value101.72M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.92M USD
Revenue/Share—
Last Price3.640 USD
Fiscal Year EndOct 2025
MR QuarterJul 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.91
PEG—
EV/EBITDA-7.72
EV/Revenue—
P/S—
P/B17.10
EPS (TTM)-0.71
EPS (Forward)-0.53
52W Range
3.0504% of range18.79
52W High18.79 USD
52W Low3.050 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-53.36%
ROA-51.03%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.67M USD
CapEx (TTM)18.67K USD
FCF Margin—
FCF Yield-5.25%
Net Debt-1.52M USD
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity7.76
Current Ratio5.31
Quick Ratio1.55
Book Value/Sh0.21 USD
Cash/Share0.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)20.00 USD
Upside (mean)+449.5%
Target Range20.00 USD – 20.00 USD
# Analysts1
Ownership
Shares Out.28.21M
Float15.54M
Insiders52.06%
Institutions7.59%
Short Interest
Short Ratio0.6d
Short % Out.0.61%
Shares Short172.08K
Short (prev mo.)129.46K
Technical
SMA 506.362 (-42.8%)
SMA 2008.873 (-59.0%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)212.91K
Avg Vol (10d)166.54K
Technical Indicators
RSI (14)36.4
MACD-0.8143
MACD Signal-0.8939
MACD Hist.+0.0796
BB Upper5.375 USD
BB Middle4.107 USD
BB Lower2.839 USD
BB Width61.75%
ATR (14)0.5009 USD
Vol Ratio (20d)1.23x